Advertisement
Screener

SpyGlass Pharma, Inc. (SGP) Operating Income

SpyGlass Pharma, Inc. Operating Income

SpyGlass Pharma, Inc. (SGP) reported Operating Income of -$21.97 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-06

  • SpyGlass Pharma, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$21.97M.
  • SpyGlass Pharma, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$15.41M.
  • SpyGlass Pharma, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$9.30M.
  • SpyGlass Pharma, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$7.42M.
  • SpyGlass Pharma, Inc. operating income (loss) for fiscal 2025 was -$41.45M.
  • SpyGlass Pharma, Inc. operating income (loss) for fiscal 2024 was -$27.06M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 12 month
2026-06-30-$21.97M
10-Q · filed 2026-08-06
-$37.38M
10-Q · filed 2026-08-06
2026-03-31-$15.41M
10-Q · filed 2026-05-14
2025-12-31-$41.45M
10-K · filed 2026-03-26
2025-06-30-$9.30M
10-Q · filed 2026-08-06
-$16.72M
10-Q · filed 2026-08-06
2025-03-31-$7.42M
10-Q · filed 2026-05-14
2024-12-31-$27.06M
10-K · filed 2026-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B